Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models-Reference-Cited by-同舟云学术

Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models

Published:2021-04 Issue: Volume:124 Page:327-335
ISSN:1742-7061
Container-title:Acta Biomaterialia
language:en
Short-container-title:Acta Biomaterialia

Author:

Zhang Maofan,Hagan C. Tilden^ORCID,Foley Hayley^ORCID,Tian Xi,Yang Feifei,Au Kin Man,Mi Yu,Medik Yusra,Roche Kyle,Wagner Kyle,Rodgers Zachary,Min Yuanzeng,Wang Andrew Z.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology

Reference51 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020

2. Prognostic factors in stage III non-small-cell lung cancer patients;Urvay;Asian Pac. J. Cancer Prev.,2016

3. The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies;Movsas;Int. J. Radiat. Oncol. Biol. Phys.,1999

4. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group;Pignon;J. Clin. Oncol.,2008

5. Competing Events determining relapse-free survival in limited small-cell lung carcinoma;Arriagada;J. Clin. Oncol.,1992

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoencapsulation of etoposide promotes increased long-term DNA damage, greater induction of senescence and reduces population regrowth of lung cancer cells;Journal of Drug Delivery Science and Technology;2024-10

2. Development of CD33-Targeted Dual Drug-Loaded Nanoparticles for the Treatment of Pediatric Acute Myeloid Leukemia;Biomacromolecules;2024-09-05

3. IL-22: A key inflammatory mediator as a biomarker and potential therapeutic target for lung cancer;Heliyon;2024-09

4. Revolutionizing Lung Cancer Treatment: Nanotechnology-Driven Advances in Targeted Drug Delivery and Novel Therapeutic Strategies;Journal of Drug Delivery Science and Technology;2024-09

5. Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems;WIREs Nanomedicine and Nanobiotechnology;2024-07